J. Dewar

发表

Association between β2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics

Brian Lipworth, I. Hall, B. Lipworth, 1997, The Lancet.

The glutamine 27 beta2-adrenoceptor polymorphism is associated with elevated IgE levels in asthmatic families.

I. Hall, N. Morton, A. Wheatley, 1997, The Journal of allergy and clinical immunology.

Personalised prescribing for asthma ‐ is pharmacogenetics the answer?

I. Hall, J. Dewar, 2003, The Journal of pharmacy and pharmacology.

Linkage analysis of the 5q31–33 candidate region for asthma in 240 UK families

N. Morton, B. Beghé, S. Holgate, 2001, Genes and Immunity.

Possible role of the 4G/5G polymorphism of the plasminogen activator inhibitor 1 gene in the development of asthma.

I. Hall, A. Wheatley, J. D. Del Mundo, 2001, The Journal of allergy and clinical immunology.

Association of glutamine 27 polymorphism of β2 adrenoceptor with reported childhood asthma: population based study

I. Hall, A. Wheatley, P. Helms, 1998, BMJ.

Association of the Gln 27 beta 2-adrenoceptor polymorphism and IgE variability in asthmatic families.

I. Hall, N. Morton, A. Wheatley, 1997, Chest.

Methods for Determining β(2)-Adrenoreceptor Genotype.

I. Hall, A. Wheatley, J. Dewar, 2000 .

Fc(epsilon)RI-(beta) polymorphisms unlikely to contribute substantially to genetic risk of allergic disease

I. Hall, A. Wheatley, J. Dewar, 1996, BMJ.

&bgr;2-Adrenoceptor Polymorphism Determines Vascular Reactivity in Humans

A. Wheatley, J. Cockcroft, J. P. Noon, 2000, Hypertension.

Identification of the autoantigen SART-1 as a candidate gene for the development of atopy.

I. Hall, A. Wheatley, J. Hewitt, 2002, Human molecular genetics.